Session 2. How to potentiate Drug Discovery in SPain?
El objetivo principal de la SDDN es la creación de foros de discusión y marcos colaborativos donde promover las interacciones entre los sectores público y privado para conseguir una mayor eficiencia de las actividades de descubrimiento y desarrollo preclínico de nuevas terapias en España.
SDDN - Spain
Emilio Diez Monedero
e10Bio DDC - Spain
Head of Global R&D
Chiesi Farmaceutici - Italy
Columbus Venture Partners - Spain
VP & Head of Department II Medicinal Chemistry
Evotec - France
Organised by SDDN in collaboration with Fundacion Medina
FUNDACIÓN CENTRO DE EXCELENCIA EN INVESTIGACIÓN DE MEDICAMENTOS INNOVADORES EN ANDALUCÍA
Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.